News

CPI-300 is a high strength of Bupropion Hydrochloride (HCl), the active ingredient in Wellbutrin XL. The company’s new submission addresses the two main issues identified by the FDA

VICTRELIS is a direct acting antiviral (DAA) agent that interferes with the ability of the hepatitis C virus to replicate by inhibiting a key viral enzyme (NS3/4A serine

Sinovac’s net loss was $3.66m for the first quarter 2011, or $0.05 loss per diluted share, compared to net loss of $1.21m, or $0.01 loss per diluted share,

Neurologix is a clinical-stage biotechnology company engaged in discovery, development and commercialization of life-altering gene transfer therapies for serious disorders of the brain and central nervous system. The

TB-403 is a humanized monoclonal antibody directed towards placental growth factor (PIGF), expected to act by blocking the formation of the new blood vessels that are required for

Fampyra 10mg MR tablet is indicated for the symptomatic improvement of walking ability in adult patients with multiple sclerosis (MS) who have shown improvement after eight weeks of

Teva intends to extend an offer to purchase all remaining outstanding shares of Taiyo. Taiyo has over 550 generic drugs in a variety of therapeutic areas and dosage

GBR 500 is an antagonist of the VLA-2 (alpha2-beta1) integrin, a receptor that plays a role in lymphocyte adhesion at inflammation sites and in the downstream release of

The company expects to recruit around 85 patients in five clinical trial centers in the Poland. The Phase III trial intends to establish whether Multikine administered before current